Search Results - "Tun, H. W."

Loss of type III transforming growth factor-β receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma by Cooper, S J, Zou, H, LeGrand, S N, Marlow, L A, von Roemeling, C A, Radisky, D C, Wu, K J, Hempel, N, Margulis, V, Tun, H W, Blobe, G C, Wood, C G, Copland, J A

“…Loss of transforming growth factor-β receptor III (TβRIII) correlates with loss of transforming growth factor-β (TGF-β) responsiveness and suggests a role for…”
Get full text

Plasmacytoma-like Posttransplant Lymphoproliferative Disorder Following Orthotopic Liver Transplantation: A Case Report by Vishnu, P, Jiang, L, Cortese, C, Menke, D.M, Tun, H.W

“…Abstract Posttransplant lymphoproliferative disorders (PTLDs) are among the most serious and potentially fatal complications of both stem-cell and solid-organ…”
Get full text

HEPATOSPLENIC T CELL LYMPHOMA: CLINICAL CHARACTERISTICS AND SURVIVAL by Baidoun, F, Alhaj Moustafa, M, Tun, H. W, Hill, B. T, Jagadeesh, D

Get full text

Etanercept Therapy for Late-Onset Idiopathic Pneumonia Syndrome After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation by Tun, H.W., Wallace, K.H., Grinton, S.F., Khoor, A., Burger, C.D.

“…Idiopathic pneumonia syndrome (IPS) is a noninfectious pulmonary complication of allogeneic hematopoietic stem cell transplantation (AHSCT), which usually…”
Get full text

AN OPEN‐LABEL TRIAL OF ORAL CA‐4948 AN IRAK4 INHIBITOR COMBINED WITH IBRUTINIB IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES by Joffe, E., Ramchandren, R., Nowakowski, G., Rosenthal, A., Tun, H. W., Lunning, M., Mead, M. D., Martinez, E., von Roemeling, R., Leslie, L.

Get full text

Hepatitis C–related posttransplant plasma cell proliferative disorder with hepatitis C virus in neoplastic plasma cells: A new posttransplant disease entity? by Tun, H.W., Krishna, M., Menke, D.M.

“…Plasma cell proliferative disorder (PCPD) developed in two patients with actively replicating hepatitis C virus (HCV) in neoplastic plasma cells after…”
Get full text

Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma by Davis, Jordan, Kimbrough, ErinMarie O, Alhaj Moustafa, Muhamad, Jiang, Liuyan, Gupta, Vivek, Parent, Ephraim, Tun, Han W

“…Primary cranial vault lymphoma (PCVL) is a rare lymphoma involving the skull with or without extra- and intracranial extension. Most cases of PCVL are diffuse…”
Get full text

Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes by Kimbrough, Erin Marie O, Jiang, Liuyan, Parent, Ephraim E, Bourgeois, Kirk, Moustafa, Muhamad Alhaj, Tun, Han W, Iqbal, Madiha

“…Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain extranodal locations such as the central nervous system (CNS), testes,…”
Get full text

Organ-Derived Decellularized Extracellular Matrix: A Game Changer for Bioink Manufacturing? by Choudhury, Deepak, Tun, Han Win, Wang, Tianyi, Naing, May Win

“…The extracellular matrix (ECM) comprises a complex milieu of proteins and other growth factors that provide mechanical, biophysical, and biochemical cues to…”
Get full text

THE DIAL STUDY (DUAL IMMUNOMODULATION IN AGGRESSIVE LYMPHOMA): RANDOMIZED PHASE 2 TRIAL OF VARLILUMAB PLUS NIVOLUMAB IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL LYMPHOMAS by Villasboas, J.C., Reeder, C.B., Tun, H.W., Bartlett, N.L., Sharon, E., LaPlant, B., Adjei, A., Ansell, S.M.

Get full text

A FIRST‐IN‐HUMAN TRIAL OF THE NOVEL MULTI‐ACTION THERAPY TINOSTAMUSTINE (EDO‐S101) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL) by Pinto, A., De Filippi, R., Zinzani, P., Driessen, C., Tun, H.W., Hilgier, K., Remmy, D., Mehrling, T., O'Connor, O.A.

Get full text

Successful Anatomy Adapted Therapeutic Management and Genetic Profiling of Primary Pituitary Diffuse Large B-Cell Lymphoma by Kimbrough, ErinMarie O, Gupta, Vivek, Jiang, Liuyan, Tun, Han W

“…Primary pituitary diffuse large B-cell lymphoma (PPL) has been regarded as a subtype of primary central nervous system lymphoma (PCNSL); however, the pituitary…”
Get full text

90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases by Wang, Jing, Baidoun, Firas, Tun, Han W, Alhaj Moustafa, Muhamad

“…Radioimmunotherapy (RIT) with radio-labeled monoclonal antibodies to CD20 produces a high response rate in patients with low-grade B-cell lymphomas. The use of…”
Get full text

Loss of type III transforming growth factor-b receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma by Cooper, S J, Zou, H, LeGrand, S N, Marlow, L A, von Roemeling, C A, Radisky, D C, Wu, K J, Hempel, N, Margulis, V, Tun, H W, Blobe, G C, Wood, C G, Copland, J A

“…Loss of transforming growth factor-b receptor III (TbRIII) correlates with loss of transforming growth factor-b (TGF-b) responsiveness and suggests a role for…”
Get full text

Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis by Wolf, Emily B, Imperial, Robin, Jiang, Liuyan, Agarwal, Amit K, Tun, Han W

“…Primary cranial neurolymphomatosis (PCNL) is a rare subtype of primary CNS lymphoma (PCNSL) in which infiltrative lymphomatous involvement is confined to…”
Get full text

Loss of type III transforming growth factor-[beta] receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma by Cooper, S.J, Zou, H, LeGrand, S.N, Marlow, L.A, von Roemeling, C.A, Radisky, D.C, Wu, K.J, Hempel, N, Margulis, V, Tun, H.W, Blobe, G.C, Wood, C.G, Copland, J.A

“…Loss of transforming growth factor-[beta] receptor III (T[beta]RIII) correlates with loss of transforming growth factor-[beta] (TGF-[beta]) responsiveness and…”
Get full text

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy by Fournier, Lyndsey L, Kimbrough, ErinMarie O, Moustafa, Muhamad Alhaj, Li, Ke, Iqbal, Madiha, Gupta, Vivek, Tun, Han W

“…Secondary central nervous system involvement by systemic diffuse large B-cell lymphoma (DLBCL) carries a very poor prognosis. We present a female patient who…”
Get full text

Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review by Kuhlman, Justin J, Moustafa, Muhamad Alhaj, Gupta, Vivek, Jiang, Liuyan, Tun, Han W

“…Primary cauda equina lymphoma is an extremely rare entity previously documented in only 24 reported cases. Primary cauda equina lymphoma represents a subtype…”
Get full text

Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations by Plante, Marie M, Kimbrough, ErinMarie O, Agarwal, Amit K, Jiang, Liuyan, Bourgeois, Kirk, Stamper, Greta C, Stewart, Michael W, Tun, Han W

“…Hyperviscosity syndrome (HVS) is an emergent complication of Waldenström macroglobulinemia (WM) characterized by visual, neurologic, and rarely auditory…”
Get full text

Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma by Kuhlman, Justin J, Alhaj Moustafa, Muhamad, Jiang, Liuyan, Wang, Jing, Gupta, Vivek, Tun, Han W

“…Primary central nervous system lymphoma (PCNSL) carries a dismal prognosis in elderly patients above 70 years of age with a median overall survival of 6…”
Get full text